We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Astrazeneca Plc | LSE:AZN | London | Ordinary Share | GB0009895292 | ORD SHS $0.25 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-6.00 | -0.05% | 12,018.00 | 12,018.00 | 12,022.00 | 12,142.00 | 11,944.00 | 11,950.00 | 1,098,253 | 16:29:59 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 45.81B | 5.96B | 3.8415 | 31.34 | 186.64B |
Date | Subject | Author | Discuss |
---|---|---|---|
04/3/2024 15:26 | They bought one in early phase development in November: hxxps://www.astrazen | andygibb101 | |
01/3/2024 13:14 | It's a shame Astra did not have the fat buster drug, Novo Nordisk and EJ Lily gone through the roof. | montyhedge | |
27/2/2024 08:15 | Astra has an IR day in May where they are expected to try to talk up their longer term growth potential | smcni1968 | |
21/2/2024 14:26 | Money moving to APH , excellent growth health care company | blackhorse23 | |
21/2/2024 10:55 | philanderer - a suggestion The link does work if you delete everything after "html" - otherwise it seems to stretch the page. | mirandaj | |
21/2/2024 00:19 | "The £135m man: That's how much Pascal Soriot has been paid in 12 years at AstraZeneca... with more to come" | philanderer | |
20/2/2024 09:46 | Berenberg cuts AstraZeneca price target to 12,000 (12,500) pence - 'buy' | philanderer | |
20/2/2024 00:23 | MARKET REPORT: Lung cancer drug gives AstraZeneca a shot in arm | philanderer | |
19/2/2024 15:03 | Hopefully the US investors will get this moving up tomorrow | smcni1968 | |
19/2/2024 10:09 | #987. Novo will need to use its new cash flows to diversify. | alphorn | |
19/2/2024 10:06 | Today's news good for the company and good for patients. | alphorn | |
14/2/2024 09:04 | Novo Nordisk the pharma to be in and Glaxo looking good. | montyhedge | |
12/2/2024 17:26 | Market report "...AstraZeneca shares came into the week on a three-day losing streak, including a more than 6% slide on the day it released annual results. "‘We think this presents a compelling entry point for a best-in-class company,’ analysts at Barclays said on Monday, however." sharesmagazine.co.uk | philanderer | |
12/2/2024 16:22 | Don't tell me you sold these to buy APH as well! If APH are so good you should follow your own advice and put all your eggs in that creaky basket. | mattboxy | |
12/2/2024 16:13 | Ex div on the 22nd, may pick up some before then. | chc15 | |
12/2/2024 15:48 | 24 month low for the shareprice. Chartwise, support at 8300p | philanderer | |
12/2/2024 11:50 | Blackhorse. No it isn't. Grow up. | tday | |
12/2/2024 11:37 | Money moving to APH | blackhorse23 | |
12/2/2024 11:11 | Quite a spread of views! It is important to bear in mind what a commentator's price target means: it is not 'current fair value', but (unless otherwise stated) a price which the commentator at present believes will be hit at some time within the following 12 months, and not necessarily sustained thereafter, still less that there will not be further rises /falls from the price at the date on which the target was stated before that figure is hit, if indeed it is hit. | 1knocker | |
12/2/2024 10:57 | Stifel cuts AstraZeneca price target to 12,000 (12,550) pence - 'buy' Barclays cuts AstraZeneca price target to 12,500 (13,500) pence - 'overweigh UBS cuts AstraZeneca price target to 9,900 (10,700) pence - 'sell' | philanderer | |
09/2/2024 14:36 | Deutsche Bank cuts AstraZeneca to 'sell' (hold) - price target 9,500 (11,000) pence | philanderer | |
08/2/2024 18:31 | Rebounding in the US listing | smcni1968 | |
08/2/2024 16:48 | "Beckers2008 - 31 Mar 2022 - 14:48:08 - 5532 of 5974 I'm out at £102. This is above quite a few broker PT's so happy to take profits. Currently way above 20 mda, too high too quickly, will buy back when it settles. Good Luck all." Should have held for a while longer, but you live and learn. GLA. | beckers2008 | |
08/2/2024 16:34 | AZN is still pretty richly priced. I think it should slide a bit more. I may put a limit order in to buy a few more at 93, though that will significantly above my average, currently 58 after a few out and back in round trips a few years back. AZN does not pay much of a dividend, and I see no catalyst to move the price north at present, so in this uncertain market I shall probably put in my order at 90 and be patient. | 1knocker |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions